Extracorporeal Membrane Oxygenation Impact on Host Transcriptomic Response in Severe Coronavirus.

ABSTRACT:

Background

Evidence suggests that patients critically ill with COVID-19 have a dysregulated host immune response that contributes to end-organ damage. Extracorporeal membrane oxygenation (ECMO) has been used in this population with varying degrees of success. This study was performed to evaluate the impact of ECMO on the host immunotranscriptomic response in these patients.

Methods

Eleven patients critically ill with COVID-19 requiring ECMO underwent an analysis of cytokines and immunotranscriptomic pathways before ECMO (T1), after ECMO for 24 hours (T2), and 2 hours after ECMO decannulation (T3). A Multiplex Human Cytokine panel was used to identify cytokine changes, and immunotranscriptomic changes in peripheral leukocytes were evaluated by PAXgene and NanoString nCounter.

SUBMITTER: Smith DE 

PROVIDER: S-EPMC10103524 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature